SCHEMBL24718015

SCHEMBL24718015

CCCC1CCC(C#Cc2ccc(Br)cc2)CC1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 3/20 0.41
FFAR4 Q5NUL3 2/20 0.36
CYP2C9 P11712 3/20 0.34
ALDH1A1 P00352 2/20 0.33
LMNA P02545 1/20 0.33
MAPT P10636 1/20 0.33
MEN1 O00255 1/20 0.33
MAPK1 P28482 1/20 0.33
KMT2A Q03164 1/20 0.33
CYP3A4 P08684 2/20 0.32
TSHR P16473 1/20 0.32
HSD17B10 Q99714 1/20 0.32
P2RY6 Q15077 1/20 0.32
HAO1 Q9UJM8 1/20 0.31
CYP2D6 P10635 1/20 0.30
PTGES O14684 1/20 0.30
ACACB O00763 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9249603 0.95 FFAR1 (0.38) FFAR1FFAR4CYP2C9ALDH1A1LMNA
SCHEMBL9249611 0.95 FFAR1 (0.38) FFAR1FFAR4CYP2C9ALDH1A1LMNA
SCHEMBL9499728 0.93 FFAR1 (0.45) FFAR1FFAR4CYP2C9ALDH1A1LMNA
SCHEMBL9855586 0.93 FFAR1 (0.45) FFAR1FFAR4CYP2C9ALDH1A1LMNA
SCHEMBL24717467 0.92 FFAR1 (0.38) FFAR1FFAR4CYP2C9ALDH1A1LMNA
SCHEMBL24717189 0.91 FFAR1 (0.38) FFAR1FFAR4CYP2C9ALDH1A1LMNA
SCHEMBL9246197 0.89 FFAR1 (0.36) FFAR1FFAR4CYP2C9ALDH1A1LMNA
SCHEMBL9246190 0.89 FFAR1 (0.36) FFAR1FFAR4CYP2C9ALDH1A1LMNA
SCHEMBL9500386 0.86 FFAR1 (0.40) FFAR1FFAR4CYP2C9P2RY6
SCHEMBL9500523 0.86 FFAR1 (0.40) FFAR1FFAR4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240228878-A1 COMPOUND, LIQUID CRYSTAL COMPOSITION, AS WELL AS LIQUID CRYSTAL DISPLAY ELEMENT, SENSOR, LIQUID CRYSTAL LENS, OPTICAL COMMUNICATION EQUIPMENT, AND ANTENNA EACH USING THE SAME DIC CORPORATION (JP) 2024-07-11 US disclosed
US-20240228878-A1 COMPOUND, LIQUID CRYSTAL COMPOSITION, AS WELL AS LIQUID CRYSTAL DISPLAY ELEMENT, SENSOR, LIQUID CRYSTAL LENS, OPTICAL COMMUNICATION EQUIPMENT, AND ANTENNA EACH USING THE SAME DIC CORPORATION (JP) 2024-07-11 US disclosed
WO-2022234709-A1 COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT, SENSOR, LIQUID CRYSTAL LENS, OPTICAL COMMUNICATION DEVICE AND ANTENNA EACH USING SAME DIC株式会社 2022-11-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240228878-A1 COMPOUND, LIQUID CRYSTAL COMPOSITION, AS WELL AS LIQUID CRYSTAL DISPLAY ELEMENT, SENSOR, LIQUID CRYSTAL LENS, OPTICAL COMMUNICATION EQUIPMENT, AND ANTENNA EACH USING THE SAME TTI2, CCT4, CCT2 FFAR1 816/4885FFAR4 1584/4885CYP2C9 3548/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.